Document is current
Any future updates will be listed below
-
Authors
Bettiol, Alessandra
Bertsias, George https://orcid.org/0000-0001-5299-1406
Bodaghi, Bahram
Celik, Aykut Ferhat https://orcid.org/0000-0001-5277-9229
Fragoulis, George E.
Saadoun, David
Talarico, Rosaria https://orcid.org/0000-0003-4268-9611
Uygunoğlu, Uğur
Emmi, Giacomo https://orcid.org/0000-0001-9575-8321
Sfikakis, Petros P.
Hatemi, Gülen
- License Information
-
More Information
Article History
Accepted: 29 April 2026
First Online: 21 May 2026
Competing interests
: B.B. has received consulting fees from AbbVie, Alimera, Horus Pharma, Novartis and Roche. G.B. has received research grants, speaker fees and/or consulting fees from MSD, AstraZeneca, GSK, AbbVie, Lilly, Boehringer, Ostuka and UCB. G.E. has received research grants, speaker fees and consulting fees from GSK, AstraZeneca, SOBI and Novartis. G.H. has received research grants, speaker fees and consulting fees from AbbVie, Amgen, Johnson & Johnson, MSD, Novartis, Soligenix and UCB Pharma. P.P.S. has received research grants, speaker fees and consulting fees from AbbVie, Amgen, Boehringer, Eli-Lilly, Elpen, Genesis, GSK, Johnson & Johnson, MSD, Novartis, Pfizer and UCB Pharma. All other authors declare no competing interests.
